NAICS Code 621111-16 - Oncologists

Marketing Level - NAICS 8-Digit

Business Lists and Databases Available for Marketing and Research

Total Verified Companies: 1,311
Contact Emails: 8,922
Company Websites: 1,221
Phone Numbers: 1,300
Business Addresses: 1,311
Companies with Email: 412
Reach new customers, connect with decision makers, and grow your business.
Pricing from $0.05 to $0.25 per lead

Business List Pricing Tiers

Quantity of Records Price Per Record Estimated Total (Max in Tier)
0 - 1,000 $0.25 Up to $250
1,001 - 2,500 $0.20 Up to $500
2,501 - 10,000 $0.15 Up to $1,500
10,001 - 25,000 $0.12 Up to $3,000
25,001 - 50,000 $0.09 Up to $4,500
50,000+ Contact Us for a Custom Quote

What's Included in Every Standard Data Package

  • Company Name
  • Contact Name (where available)
  • Job Title (where available)
  • Full Business & Mailing Address
  • Business Phone Number
  • Industry Codes (Primary and Secondary SIC & NAICS Codes)
  • Sales Volume
  • Employee Count
  • Website (where available)
  • Years in Business
  • Location Type (HQ, Branch, Subsidiary)
  • Modeled Credit Rating
  • Public / Private Status
  • Latitude / Longitude
  • ...and more (Inquire)

Boost Your Data with Verified Email Leads

Enhance your list or opt for a complete 100% verified email list – all for just $0.10 per email!

Ideal for: Direct Mailing Email Campaigns Calling Market ResearchFree Sample & Report, Custom Lists, and Expert Support — All Included
Looking for more companies? See NAICS 621111 - Offices of Physicians (except Mental Health Specialists) - 892,121 companies, 2,360,298 emails.

NAICS Code 621111-16 Description (8-Digit)

Oncologists are medical professionals who specialize in the diagnosis and treatment of cancer. They work with patients to develop treatment plans that may include chemotherapy, radiation therapy, surgery, or a combination of these treatments. Oncologists also monitor patients' progress and adjust treatment plans as needed. They may work in hospitals, cancer centers, or private practices.

Parent Code - Official US Census

Official 6‑digit NAICS codes serve as the parent classification used for government registrations and documentation. The marketing-level 8‑digit codes act as child extensions of these official classifications, providing refined segmentation for more precise targeting and detailed niche insights. Related industries are listed under the parent code, offering a broader context of the industry environment. For further details on the official classification for this industry, please visit the U.S. Census Bureau NAICS Code 621111 page

Tools

Tools commonly used in the Oncologists industry for day-to-day tasks and operations.

  • PET scanners
  • CT scanners
  • MRI machines
  • Ultrasound machines
  • Biopsy needles
  • Radiation therapy machines
  • Chemotherapy drugs
  • Immunotherapy drugs
  • Blood tests
  • Genetic testing

Industry Examples of Oncologists

Common products and services typical of NAICS Code 621111-16, illustrating the main business activities and contributions to the market.

  • Breast cancer treatment
  • Lung cancer treatment
  • Prostate cancer treatment
  • Colorectal cancer treatment
  • Pancreatic cancer treatment
  • Leukemia treatment
  • Lymphoma treatment
  • Melanoma treatment
  • Brain cancer treatment
  • Ovarian cancer treatment

History

A concise historical narrative of NAICS Code 621111-16 covering global milestones and recent developments within the United States.

  • The history of the Oncologists industry dates back to the early 20th century when radiation therapy was first introduced as a treatment for cancer. In the 1940s, chemotherapy was developed, which revolutionized cancer treatment. In the 1970s, the first bone marrow transplant was performed, and in the 1980s, the first monoclonal antibody was approved for cancer treatment. In recent years, there have been significant advancements in precision medicine, immunotherapy, and targeted therapies. In the United States, the Oncologists industry has seen a surge in demand due to the aging population and the increasing prevalence of cancer. In the 1990s, the National Cancer Institute launched the Cancer Genome Atlas, which led to a better understanding of the genetic basis of cancer. In the 2000s, the FDA approved the first targeted therapy for cancer, and in the 2010s, immunotherapy became a game-changer in cancer treatment. Overall, the Oncologists industry has come a long way in the past century, and the advancements in technology and research have led to better outcomes for cancer patients.